Allogene Therapeutics Inc
ALLO
Market Cap$530.86M
Close$
$-0.08
103.4% downside
Current Fair Value
103.4% downsideOvervalued by 103.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $530.86 Million |
|---|---|
| Enterprise Value | $234.92 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.8 |
| Beta | 0.0 |
| Outstanding Shares | 209,000,000 |
| Avg 30 Day Volume | 2,968,069 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.81 |
|---|---|
| PEG | 5.3 |
| Price to Sales | - |
| Price to Book Ratio | 1.15 |
| Enterprise Value to Revenue | 3614.09 |
| Enterprise Value to EBIT | -0.82 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.38 |
| Debt to Equity | 0.19 |
Revenue Sources
No data
Insider Trades
ESG Score
No data